- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04830631
tDCS Response Prediction Using EEG in Stroke
May 15, 2022 updated by: Won-Seok Kim, Seoul National University Hospital
Prediction of Transcranial Direct Current Stimulation (tDCS) Responses Using Electroencephalography (EEG )in Patients With Chronic Stroke
Patients with chronic stroke (>6 months after stroke) having unilateral upper limb hemiparesis will be recruited.
Patients will maintain their usual inpatient rehabilitation including occupational therapy.
At baseline (T0) and after 2weeks of enrollment (T1), Fugl-Meyer assessment (FMA) will be assessed at each time.
And patients with the changes of FMA between T0 and T1 less than 3 points will be finally recruited.
The enrolled patients will receive additional 30-min cathodal transcranial direct current stimulation (tDCS) over the contralesional motor cortex for 10 consecutive weekdays, with maintaining their usual conventional rehabilitation.
At T1 and immediately after 10-seessions of tDCS (T2) and 1 month after completing 10-tDCS session (T3), FMA, Actional Research Arm Test (ARAT), Box and Block Test (BBT) and electroencephalography (EEG) were measured.
Study Overview
Status
Recruiting
Intervention / Treatment
Study Type
Observational
Enrollment (Anticipated)
100
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Won-Seok Kim
- Phone Number: +82317877735
- Email: wondol77@gmail.com
Study Locations
-
-
Gyeonggi-do
-
Seongnam-si, Gyeonggi-do, Korea, Republic of, 13620
- Recruiting
- Seoul National University Bundang Hospital
-
Contact:
- Won-Seok Kim
- Phone Number: 0317877735
- Email: wondol77@gmail.com
-
Principal Investigator:
- Won-Seok Kim, MD
-
-
Please Select
-
Seongnam-si, Please Select, Korea, Republic of, 13620
- Recruiting
- Rusk Rehabilitation Hospital
-
Contact:
- Chaiyoung Lim, MD
-
Principal Investigator:
- Chaiyoung Lim, MD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
19 years to 85 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Chronic stroke patients with unilateral hemiparesis
Description
Inclusion Criteria:
- age ranges from 19 to 85 yrs old
- stroke patients with unilateral hemiparesis
- 1st ever stroke
- chronic stroke (>6 months after stroke)
Exclusion Criteria:
- recurrent stroke
- history of traumatic brain injury
- Minimental state examination score is 15 or less.
- Unstable medical conditions
- Severe delirium, disorders of consciousness
- pregnancy
- can not attach tDCS electrode on the scalp due to skin conditions
- can not maintain the sitting position
- intracranial metals
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Changes in Fugl-Meyer Assesment Score 1
Time Frame: Between T1 (before tDCS) and T2 (immediately after completing 10 sessions of tDCS)
|
Between T1 (before tDCS) and T2 (immediately after completing 10 sessions of tDCS)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Changes in Fugl-Meyer Assesment Score 2
Time Frame: Between T2 (immediately after completing 10 sessions of tDCS) and T3 (1 month after completing 10 sessions of tDCS)
|
Between T2 (immediately after completing 10 sessions of tDCS) and T3 (1 month after completing 10 sessions of tDCS)
|
|
Changes in Action Research Arm Test Score 1
Time Frame: Between T1 (before tDCS) and T2 (immediately after completing 10 sessions of tDCS)
|
Between T1 (before tDCS) and T2 (immediately after completing 10 sessions of tDCS)
|
|
Changes in Action Research Arm Test Score 2
Time Frame: Between T2 (immediately after completing 10 sessions of tDCS) and T3 (1 month after completing 10 sessions of tDCS)
|
Between T2 (immediately after completing 10 sessions of tDCS) and T3 (1 month after completing 10 sessions of tDCS)
|
|
Changes in Box and Block Test Score 1
Time Frame: Between T1 (before tDCS) and T2 (immediately after completing 10 sessions of tDCS)
|
Between T1 (before tDCS) and T2 (immediately after completing 10 sessions of tDCS)
|
|
Changes in Box and Block Test Score 2
Time Frame: Between T2 (immediately after completing 10 sessions of tDCS) and T3 (1 month after completing 10 sessions of tDCS)
|
Between T2 (immediately after completing 10 sessions of tDCS) and T3 (1 month after completing 10 sessions of tDCS)
|
|
Changes in EEG index1
Time Frame: Between T1 (before tDCS) and T2 (immediately after completing 10 sessions of tDCS)
|
Various kinds of EEG indexe.g., network indexes, event-related dysynchronization, mu suppression) will be surveyed.
|
Between T1 (before tDCS) and T2 (immediately after completing 10 sessions of tDCS)
|
Changes in EEG index 2
Time Frame: Between T2 (immediately after completing 10 sessions of tDCS) and T3 (1 month after completing 10 sessions of tDCS)
|
Various kinds of EEG indexe.g., network indexes, event-related dysynchronization, mu suppression) will be surveyed.
|
Between T2 (immediately after completing 10 sessions of tDCS) and T3 (1 month after completing 10 sessions of tDCS)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 1, 2020
Primary Completion (Anticipated)
March 1, 2024
Study Completion (Anticipated)
March 1, 2024
Study Registration Dates
First Submitted
March 31, 2021
First Submitted That Met QC Criteria
March 31, 2021
First Posted (Actual)
April 5, 2021
Study Record Updates
Last Update Posted (Actual)
May 17, 2022
Last Update Submitted That Met QC Criteria
May 15, 2022
Last Verified
May 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- B-2004/608-004
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
IPD Plan Description
After completing the study, EEG indexes and behavioral outcomes will be considered to be shared with researchers who have the clear and reasonable purpose to use our data.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stroke
-
University Hospital, GhentRecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Stroke HemorrhagicBelgium
-
Moleac Pte Ltd.RecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, CryptogenicSingapore, Philippines
-
Moleac Pte Ltd.Not yet recruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, Cryptogenic
-
IRCCS San Camillo, Venezia, ItalyRecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke HemorrhagicItaly
-
Vanderbilt University Medical CenterPatient-Centered Outcomes Research Institute; University of Alabama at BirminghamEnrolling by invitationStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Engagement, Patient | Stroke HemorrhagicUnited States
-
University of MinnesotaAmerican Occupational Therapy FoundationRecruitingStroke | Stroke Sequelae | Stroke Hemorrhagic | Stroke IschemicUnited States
-
University of British ColumbiaCanadian Institutes of Health Research (CIHR); Michael Smith Foundation for...RecruitingStroke | Stroke, Ischemic | Stroke Hemorrhagic | Chronic StrokeCanada
-
University of CincinnatiMedical University of South Carolina; University of California, Los Angeles; University...RecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke HemorrhagicUnited States
-
Turkish Stroke Research and Clinical Trials NetworkElectroCore INC; Turkish Neurological SocietyCompletedStroke | Stroke, Ischemic | Stroke, Acute | Stroke, HemorrhagicTurkey
-
University of LiegeCompletedStroke, Acute | Stroke Hemorrhagic | Stroke, ComplicationBelgium
Clinical Trials on Cathodal transcranial direct current stimulation (tDCS) over the contralesional motor cortex
-
University Hospital, GrenobleCompletedChronic Migraine as Defined by Criteria of International Headache Society (IHS)France
-
Charite University, Berlin, GermanyTerminatedNeuralgia | Neuropathic PainGermany
-
University Hospital TuebingenActive, not recruitingObesity | Insulin Resistance | Diabetes Type 2Germany
-
University Hospital TuebingenGerman Center for Diabetes ResearchUnknownInsulin Resistance | Transcranial Direct Current StimulationGermany
-
University Hospital TuebingenCompleted
-
Mahidol UniversityRecruiting
-
University of CalgaryThe Hospital for Sick Children; University of Alberta; Holland Bloorview Kids...CompletedHemiplegic Cerebral Palsy | Perinatal StrokeCanada
-
Neuroelectrics CorporationBeth Israel Deaconess Medical Center; Boston Children's HospitalCompletedRefractory EpilepsyUnited States
-
IRCCS Centro San Giovanni di Dio FatebenefratelliAzienda Ospedaliero, Universitaria Pisana; Azienda Ospedaliera Universitaria... and other collaboratorsUnknownStroke, Ischemic | Stroke HemorrhagicItaly
-
Yale UniversityNational Institute on Drug Abuse (NIDA)CompletedNicotine Withdrawal | Tobacco AbstinenceUnited States